Sachin Narain, MD
Interventional Pain Medicine · Gilbert, AZNPI 1790009231
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.7%), food and beverage and education — rather than concentrated in one kind of arrangement. Abbott accounts for 67.0% of it on its own, with 34 other manufacturers making up the rest.
Across 618 payments — averaging $50.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$21K
- Spinefrontier, Inc.$2K
- Impactortho, Inc.$2K
- Painteq LLC$1K
- Boston Scientific$1K
- Nevro Corp.$584
- plus $3K from 29 others
What the payments were for
- Consulting fees$14,29746%
- Travel & lodging$1,8346%
- Food & beverage$12,56540%
- Education$2,5998%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 358 | $20,960 |
| Spinefrontier, Inc. | 9 | $2,463 |
| Impactortho, Inc. | 3 | $2,193 |
| Painteq LLC | 29 | $1,253 |
| Boston Scientific | 57 | $1,167 |
| Nevro Corp. | 41 | $584 |
| Vertos Medical, Inc. | 3 | $400 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $296 |
| Biotronik NRO, Inc. | 8 | $226 |
| Nalu Medical, Inc. | 6 | $202 |
| Medtronic | 23 | $200 |
| Protega Pharmaceutials Inc | 6 | $175 |
| Almatica Pharma LLC | 8 | $137 |
| Scilex Pharmaceuticals Inc. | 8 | $130 |
| Acacia Pharma Inc | 1 | $121 |
| Alevio, LLC | 1 | $108 |
| AbbVie(2 entities) | 6 | $99 |
| Pfizer | 6 | $84 |
| Curonix LLC | 1 | $80 |
| Foundation Fusion Solutions, LLC | 7 | $51 |
| Stimwave Technologies Incorporated | 2 | $46 |
| Saluda Medical Americas, Inc. | 1 | $40 |
| Relievant Medsystems, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Orthogenrx Inc. | 1 | $28 |
| Si-bone, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Convatec Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Shionogi Inc | 1 | $19 |
| Globus Medical | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$12,728
- PRODIGY$2,500
- Sacrix$1,834
- PAINTEQ$751
- InSpan$329
- SIJFuse$329
- FacetFuse$329
- NanoFuse$329
- mild Device Kit$321
- ETERNA$272
- Intracept$159
- Proclaim IPG$121
- BYFAVO$121
- SICURE SACROILIAC JOINT FUSION SYSTEM$108
- Nalu Neurostimulation System$108
How this compares
$31,294 in reported general payments places this provider in the 85th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 381 | $9,189 |
| Xtampza ErOxycodone Myristate | 18 | $7,278 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 206 | $5,389 |
| Gabapentin | 282 | $4,165 |
| Pregabalin | 111 | $3,163 |
| Diclofenac Sodium | 137 | $2,496 |
| Oxycodone Hcl | 153 | $2,267 |
| Tizanidine Hcl | 178 | $2,226 |
| Morphine Sulfate ErMorphine Sulfate | 59 | $1,398 |
| Mupirocin | 126 | $964 |
| Baclofen | 50 | $964 |
| Methocarbamol | 54 | $894 |
| Tramadol Hcl ErTramadol Hcl | 12 | $891 |
| Tramadol Hcl | 81 | $764 |
| Cyclobenzaprine Hcl | 35 | $500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $32 | $7,27818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 64 interventional pain medicine providers in Arizona.
Other interventional pain medicine in Gilbert
- Ajay YedduGilbert$52K
- Ahdev KuppusamyGilbert$25K
- Joseph CurlettaGilbert$8K
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
- Jennifer DaisPeoria$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.